摘要
测定血清谷胱甘肽S-转移酶(GST)活性的结果表明,肺癌患者的血清GST活性(21.1±8.2IU/L)与正常人的(15.6±7.6IU/L)及肺部良性病患者的(16.3±9.1IU/L)均有极显著性差异(P<0.01),肺癌患者手术前后的无显著性意义(P>0.05)。由于个体差异明显,该结果对肺癌的诊断价值不大。发展免疫学方法测定患者血清GST各类同功酶则非常必要,此项工作正在进行中。
Serum glutathione S-transferase(GST)activity in the patients with lung malignancies (21. 4±8. 2IU/L)was significantly higher (P<0. Dl)than that of health control (15. 6±7. 6IU/L)and that of the patients with lung benign diseases (16. 3±9. 1IU/L)respectively. But large individual variations were found. It is necessary to measure the serum GST isoenzymes separately with immunological assays.
出处
《河南肿瘤学杂志》
1992年第1期7-8,共2页
Henan Journal of Oncology
关键词
肺肿瘤
谷胱甘肽
S-转移酶
GST
glutathione s-transferae activity
lung disease
lung carcinoma
